Page last updated: 2024-09-04

tipifarnib and azd2014

tipifarnib has been researched along with azd2014 in 1 studies

Compound Research Comparison

Studies
(tipifarnib)
Trials
(tipifarnib)
Recent Studies (post-2010)
(tipifarnib)
Studies
(azd2014)
Trials
(azd2014)
Recent Studies (post-2010) (azd2014)
309929476872

Protein Interaction Comparison

ProteinTaxonomytipifarnib (IC50)azd2014 (IC50)
Phosphatidylinositol 3-kinase regulatory subunit alphaHomo sapiens (human)3.8
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoformHomo sapiens (human)3.8
Serine/threonine-protein kinase mTORHomo sapiens (human)0.0521
Regulatory-associated protein of mTORHomo sapiens (human)0.2
Target of rapamycin complex subunit LST8Homo sapiens (human)0.2

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Babic, T; Buric, SS; Dinic, J; Hadzic, S; Pesic, M; Radojkovic, D; Rankov, AD1

Other Studies

1 other study(ies) available for tipifarnib and azd2014

ArticleYear
Comparative toxicity evaluation of targeted anticancer therapeutics in embryonic zebrafish and sea urchin models.
    Acta biologica Hungarica, 2018, Volume: 69, Issue:4

    Topics: Abnormalities, Drug-Induced; Animals; Antineoplastic Agents; Arbacia; Benzamides; Cell Proliferation; Dose-Response Relationship, Drug; Embryonic Development; Enzyme Inhibitors; Molecular Targeted Therapy; Morpholines; Oxadiazoles; Pyrimidines; Quinolones; Signal Transduction; Wortmannin; Zebrafish

2018